Table 1.
Study characteristic.
| Author | Year | Population | HF population | Type of study | Country | AF type | HF type | Ablation technique | Pre ablation LVEF (%) | Post ablation LVEF (%) | Catheter | Freedom from AA at 12 months in CB (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pruszkowska | 2018 | 89 | 30 | Observational | Poland | pAF/peAF | HFrEF | PVI | 30 | 37 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 43.3 |
| Heeger | 2019 | 551 | 50 | Observational | Germany | pAF/peAF | HFrEF | PVI | 37 | 55 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 73.1 |
| Maj | 2019 | 38 | 38 | Observational | Italy | pAF/peAF | HFrEF | PVI | 37.3 | 40.7 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 76.3 |
| Pott | 2020 | 414 | 113 | Observational | Germany | pAF/peAF | HFrEF | PVI | 38.4 | 52.5 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 64.6 |
| Prabhu | 2021 | 76 | 76 | Observational | Australia | pAF/peAF | HFrEF | PVI | 32 | 45 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 70 |
| Rordorf | 2021 | 1303 | 318 | Observational | Asia and Europe | pAF/peAF | HFrEF/HFpEF | PVI | 58 | NA | Arctic Front Advance Pro (Medtronic) | 80.5 |
| Chen | 2022 | 471 | 216 | Observational | China | pAF/peAF | HFpEF/HFmEF/HFrEF | PVI | NA | NA | 2nd Generation Cryoablation Arctic Front (Medtronic) | 91.6 |
| Yanagisawa | 2022 | 3655 | 549 | Observational | Japan | pAF/peAF | HFrEF/HFpEF | PVI | 56.2 | 59.7 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 80.1 |
| Zylla | 2022 | 102 | 24 | Observational | Germany | pAF/peAF | HFpEF | PVI | 57.1 | 56.3 | 2nd Generation Cryoablation Arctic Front (Medtronic) | 41.6 |